The association between LOC129390655 (MPRA-Validated Peak2221 Silencer) and Neurodevelopmental Disorder With Hypotonia, Poor Growth, Dysmorphic Facies, And Agammaglobulinemia is supported by expert-curated evidence, drawing on a single expert-curated source, which records pathogenic variants.
Sources1
Clinical variants1
Symptoms65
Compounds0
Trials0
Publications2
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.